Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue | $30.4K | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $658.8K | $835.5K | $1.0M | $172.6K | $182.4K | $170.7K | $83.8K |
| Gross profit | −$628.4K | −$835.5K | −$1.0M | −$172.6K | −$182.4K | −$170.7K | −$83.8K |
| Gross margin | -2069.1% | — | — | — | — | — | — |
| R&D | $853.2K | $971.8K | $1.1M | $1.2M | $2.0M | $2.2M | $502.5K |
| Operating income | −$2.6M | −$2.7M | −$3.2M | −$3.2M | −$5.2M | −$4.9M | −$2.0M |
| EBITDA | −$2.1M | −$2.4M | −$3.2M | −$3.8M | −$6.0M | −$6.1M | −$1.9M |
| Net income | −$2.6M | −$2.7M | −$3.1M | −$3.9M | −$4.5M | −$3.8M | −$2.0M |
| Net margin | -8584.6% | — | — | — | — | — | — |
| EPS (diluted) | -0.35 | -0.31 | -0.29 | -0.31 | -0.31 | -0.24 | -0.09 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds COTQF.
No tracked institution reports a position in COTQF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2017-06-30 | 1-for-10reverse |
No one on the platform has traded COTQF yet.
| $2171 |
| — |
| IBXGiBX Group, Inc. | $0.00 | +0.00% | $1975 | — |
| NMTRQ9 Meters Biopharma, Inc. | $0.00 | +0.00% | $145 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.